Revisiting the multiple roles of T-cadherin in health and disease

Achari, 2017, Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction, Int. J. Mol. Sci., 18, 1321, 10.3390/ijms18061321 Adachi, 2006, An adiponectin receptor, T-cadherin, was selectively expressed in intratumoral capillary endothelial cells in hepatocellular carcinoma: possible cross talk between T-cadherin and FGF-2 pathways, Virchows Arch., 448, 311, 10.1007/s00428-005-0098-9 Alobeidy, 2013, The association study between twenty one polymorphisms in seven candidate genes and coronary heart diseases in chinese han population, PLoS One, 8, 10.1371/journal.pone.0066976 Arita, 1999, Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity, Biochem. Biophys. Res. Commun., 257, 79, 10.1006/bbrc.1999.0255 Balatskaya, 2016, T-cadherin as a novel receptor regulating metabolism in the blood vessel and heart cells: from structure to function, J. Evol. Biochem. Physiol., 2, 103, 10.1134/S0022093016020010 Balatskaya, 2019, Different spatiotemporal organization of GPI-anchored T-cadherin in response to low-density lipoprotein and adiponectin, Biochim. Biophys. Acta - Gen. Subj., 1863, 10.1016/j.bbagen.2019.129414 Bochkov, 1991, LDL- and agonist-induced Ca(2+)-mobilization in platelets of healthy subjects and in patients with familial hyperlipoproteinemia type II, Thromb. Res., 61, 403, 10.1016/0049-3848(91)90654-F Bochkov, 1993, Concerted effects of lipoproteins and angiotensin II on signal transduction processes in vascular smooth muscle cells, Arterioscler. Thromb. A J. Vasc. Biol., 13, 1261, 10.1161/01.ATV.13.9.1261 Bochkov, 1996, Ligand selectivity of 105 kDa and 130 kDa lipoprotein-binding proteins in vascular-smooth-muscle-cell membranes is unique, Biochem. J., 317, 297, 10.1042/bj3170297 Borges, 2016, Role of adiponectin in coronary heart disease risk: a mendelian randomization study, Circ. Res., 119, 491, 10.1161/CIRCRESAHA.116.308716 Bühler, 1991, Low- and high-density lipoproteins as hormonal regulators of platelet, vascular endothelial and smooth muscle cell interactions: relevance to hypertension, J. Hypertens. Suppl., 9, S28, 10.1097/00004872-199112006-00005 Burl, 2018, Deconstructing adipogenesis induced by β3-adrenergic receptor activation with single-cell expression profiling, Cell Metab., 28, 300, 10.1016/j.cmet.2018.05.025 Challa, 2015, Regulation of de novo adipocyte differentiation through cross talk between adipocytes and preadipocytes, Diabetes, 64, 4075, 10.2337/db14-1932 Ciatto, 2010, T-cadherin structures reveal a novel adhesive binding mechanism, Nat. Struct. Mol. Biol., 17, 339, 10.1038/nsmb.1781 Cohen, 2011, ADIPOQ, ADIPOR1, and ADIPOR2 polymorphisms in relation to serum adiponectin levels and BMI in black and white women, Obesity (Silver Spring), 19, 2053, 10.1038/oby.2010.346 Dames, 2008, Insights into the low adhesive capacity of human T-cadherin from the NMR structure of Its N-terminal extracellular domain, J. Biol. Chem., 283, 23485, 10.1074/jbc.M708335200 Deepa, S.S., and L.Q. Dong. 2009. APPL1: role in adiponectin signaling and beyond. https://doi.org/10.1152/ajpendo.90731.2008. 296:22–36. doi:10.1152/AJPENDO.90731.2008. Denzel, 2010, T-cadherin is critical for adiponectin-mediated cardioprotection in mice, J. Clin. Investig., 120, 4342, 10.1172/JCI43464 Dhillon, 2011, Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer, Cancer Epidemiol. Biomarkers Prev., 20, 2618, 10.1158/1055-9965.EPI-11-0434 Ebrahimi-Mameghani, 2015, Adiponectin as a potential biomarker of vascular disease, Vasc. Health Risk Manag., 11, 55 Ebrahimi-Mameghani, 2015, Adiponectin as a potential biomarker of vascular disease, Vasc. Health Risk Manag., 11, 55 Fredette, 1996, Inhibition of motor axon growth by T-cadherin substrata, Development, 122, 3163, 10.1242/dev.122.10.3163 Fredette, 1994, T-cadherin expression delineates specific regions of the developing motor axon-hindlimb projection pathway, J. Neurosci., 14, 7331, 10.1523/JNEUROSCI.14-12-07331.1994 Frismantiene, 2016, T-cadherin promotes vascular smooth muscle cell dedifferentiation via a GSK3β-inactivation dependent mechanism, Cell. Signal., 28, 516, 10.1016/j.cellsig.2016.02.014 Fruebis, J., T. Tsao, S. Javorschi, D. Ebbets-Reed, M. Erickson, F. Yen, B. Bihain, H. Lodish. 2001. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. U. S. A. 98:2005–2010. doi:〈10.1073/PNAS.041591798〉. Frystyk, 2007, Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men, J. Clin. Endocrinol. Metab., 92, 571, 10.1210/jc.2006-1067 Fujishima, 2017, Adiponectin association with T-cadherin protects against neointima proliferation and atherosclerosis, FASEB J, 31, 1571, 10.1096/fj.201601064R Fukuda, 2017, The unique prodomain of T-cadherin plays a key role in adiponectin binding with the essential extracellular cadherin repeats 1 and 2, J. Biol. Chem., 292, 7840, 10.1074/jbc.M117.780734 Gardener, 2013, Adiponectin and risk of vascular events in the Northern Manhattan study, Atherosclerosis, 226, 483, 10.1016/j.atherosclerosis.2012.11.020 George, 2006, Cadherin:catenin complex: a novel regulator of vascular smooth muscle cell behaviour, Atherosclerosis, 188, 1, 10.1016/j.atherosclerosis.2005.12.017 Göddeke, 2018, CDH13 abundance interferes with adipocyte differentiation and is a novel biomarker for adipose tissue health, Int. J. Obes., 42, 1039, 10.1038/s41366-018-0022-4 Goldstein, 1977, The low-density lipoprotein pathway and its relation to atherosclerosis, Annu. Rev. Biochem., 46, 897, 10.1146/annurev.bi.46.070177.004341 Gomez, 2012, Smooth muscle cell phenotypic switching in atherosclerosis, Cardiovasc. Res., 95, 156, 10.1093/cvr/cvs115 Harrington, 2004, The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins, J. Cell Biol., 166, 213, 10.1083/jcb.200403069 Haruta, 2000, A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1, Mol. Endocrinol., 14, 783, 10.1210/mend.14.6.0446 Hebbard, 2014, Multifaceted roles of Adiponectin in cancer, Best Pract. Res. Clin. Endocrinol. Metab., 28, 59, 10.1016/j.beem.2013.11.005 Hebbard, 2008, T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model, Cancer Res., 68, 1407, 10.1158/0008-5472.CAN-07-2953 Herring, 2013, Microparticles in health and disease, J. Vet. Intern. Med., 27, 1020, 10.1111/jvim.12128 Holland, 2007, Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance, Cell Metab., 5, 167, 10.1016/j.cmet.2007.01.002 Holley, 2015, Comparative quantification of the surfaceome of human multipotent mesenchymal progenitor cells, Stem Cell Reports, 4, 473, 10.1016/j.stemcr.2015.01.007 Hug, C., J. Wang, N. Ahmad, J. Bogan, T. Tsao, H. Lodish. 2004a. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc. Natl. Acad. Sci. U. S. A. 101:10308–10313. doi:〈10.1073/PNAS.0403382101〉. Hug, 2004, T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin, Proc. Natl. Acad. Sci., 101, 10308, 10.1073/pnas.0403382101 Hugel, B., M.C. Martínez, C. Kunzelmann, and J.-M. Freyssinet. 2005. Membrane microparticles: two sides of the coin, Membrane Microparticles: Two Sides of the Coin. https://doi.org/10.1152/physiol.00029.2004. 20:22–27. doi:10.1152/PHYSIOL.00029.2004. Hulpiau, 2009, Molecular evolution of the cadherin superfamily, Int. J. Biochem. Cell Biol., 41, 349, 10.1016/j.biocel.2008.09.027 Iglseder, 2005, Plasma adiponectin levels and sonographic phenotypes of subclinical carotid artery atherosclerosis, Stroke, 36, 2577, 10.1161/01.STR.0000190834.00284.fd Ivanov, 2001, Expression of cell adhesion molecule T-cadherin in the human vasculature, Histochem. Cell Biol., 115, 231, 10.1007/s004180100252 Jee, 2010, Adiponectin concentrations: a genome-wide association study, Am. J. Hum. Genet., 87, 545, 10.1016/j.ajhg.2010.09.004 Kadowaki, 2005, Adiponectin and adiponectin receptors, Endocr. Rev., 26, 439, 10.1210/er.2005-0005 Kadowaki, 2006, Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome, J. Clin. Investig., 116, 1784, 10.1172/JCI29126 Kipmen-Korgun, 2005, T-cadherin mediates low-density lipoprotein-initiated cell proliferation via the Ca(2+)-tyrosine kinase-Erk1/2 pathway, J. Cardiovasc. Pharmacol., 45, 418, 10.1097/01.fjc.0000157458.91433.86 Kita, 2019, Native adiponectin in serum binds to mammalian cells expressing T-cadherin, but not AdipoRs or calreticulin, Elife., 8, 10.7554/eLife.48675 Kobayashi, 2004, Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin, Circ. Res., 94, 94, 10.1161/01.RES.0000119921.86460.37 Kobayashi, 2005, Adiponectin inhibits the binding of low-density lipoprotein to biglycan, a vascular proteoglycan, Biochem. Biophys. Res. Commun., 335, 66, 10.1016/j.bbrc.2005.07.048 Kotova, 2014, Functional expression of adrenoreceptors in mesenchymal stromal cells derived from the human adipose tissue, Biochim. Biophys. Acta - Mol. Cell Res., 1843, 1899, 10.1016/j.bbamcr.2014.05.002 Kumada, 2003, Association of hypoadiponectinemia with coronary artery disease in men, Arterioscler. Thromb. Vasc. Biol., 23, 85, 10.1161/01.ATV.0000048856.22331.50 Kyriakakis, 2010, T-cadherin attenuates the PERK branch of the unfolded protein response and protects vascular endothelial cells from endoplasmic reticulum stress-induced apoptosis, Cell. Signal., 22, 1308, 10.1016/j.cellsig.2010.04.008 Lee, 1996, H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer, Nat. Med., 2, 776, 10.1038/nm0796-776 Lemos, 2018, Tissue-resident mesenchymal stromal cells: Implications for tissue-specific antifibrotic therapies, Sci. Transl. Med., 10, 10, 10.1126/scitranslmed.aan5174 Maeda, 2020, Adiponectin, a unique adipocyte-derived factor beyond hormones, Atherosclerosis, 292, 1, 10.1016/j.atherosclerosis.2019.10.021 McWilliam, J. Cadherins types, structure and functions. Menzaghi, 2018, The adiponectin paradox for all-cause and cardiovascular mortality, Diabetes, 67, 12, 10.2337/dbi17-0016 Merrick, 2019, Identification of a mesenchymal progenitor cell hierarchy in adipose tissue, Science, 364, 364, 10.1126/science.aav2501 Nakamura, 2020, Adiponectin stimulates exosome release to enhance mesenchymal stem-cell-driven therapy of heart failure in mice, Mol. Ther., 28, 2203, 10.1016/j.ymthe.2020.06.026 Nguyen, 2020, Adiponectin: role in physiology and pathophysiology, Int. J. Prev. Med., 11, 136, 10.4103/ijpvm.IJPVM_193_20 Nicolas, 2017, T-cadherin gene variants are associated with type 2 diabetes and the Fatty Liver Index in the French population, Diabetes Metab., 43, 33, 10.1016/j.diabet.2016.05.005 Obata, 2018, Adiponectin/T-cadherin system enhances exosome biogenesis and decreases cellular ceramides by exosomal release, JCI Insight, 3, 3, 10.1172/jci.insight.99680 Okamoto, 2002, Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice, Circulation, 106, 2767, 10.1161/01.CIR.0000042707.50032.19 Orlova, E.V., M.B. Sherman, W. Chiu, H. Mowri, L.C. Smith, A.M. Gotto. 1999. Three-dimensional structure of low density lipoproteins by electron cryomicroscopy. Proc. Natl. Acad. Sci. 96:8420–8425. doi:〈10.1073/PNAS.96.15.8420〉. Ouchi, 2004, Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells, J. Biol. Chem., 279, 1304, 10.1074/jbc.M310389200 Ozes, O., H. Akca, L. Mayo, J. Gustin, T. Maehama, J. Dixon, D. Donner. 2001. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc. Natl. Acad. Sci. U. S. A. 98:4640–4645. doi:〈10.1073/PNAS.051042298〉. Pajvani, 2003, Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin implications for metabolic regulation and bioactivity, J. Biol. Chem., 278, 9073, 10.1074/jbc.M207198200 Pajvani, 2004, Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity, J. Biol. Chem., 279, 12152, 10.1074/jbc.M311113200 Parker-Duffen, 2013, T-cadherin is essential for adiponectin-mediated revascularization, J. Biol. Chem., 288, 24886, 10.1074/jbc.M113.454835 Pascolutti, 2020, Mapping and engineering the interaction between adiponectin and T-cadherin, J. Biol. Chem., 295, 2749, 10.1074/jbc.RA119.010970 Peters, 2013, A comprehensive investigation of variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/R2), and their association with serum adiponectin, type 2 diabetes, insulin resistance and the metabolic syndrome, BMC Med. Genet., 14, 15, 10.1186/1471-2350-14-15 Philippova, 2006, Atypical GPI-anchored T-cadherin stimulates angiogenesis in vitro and in vivo, Arterioscler. Thromb. Vasc. Biol., 26, 2222, 10.1161/01.ATV.0000238356.20565.92 Philippova, 2005, RhoA and Rac mediate endothelial cell polarization and detachment induced by T-cadherin, FASEB J., 19, 1, 10.1096/fj.04-2430fje Philippova, 2008, Identification of proteins associating with glycosylphosphatidylinositol-anchored T-cadherin on the surface of vascular endothelial cells: role for Grp78/BiP in T-cadherin-dependent cell survival †, Mol. Cell. Biol., 28, 4004, 10.1128/MCB.00157-08 Philippova, 2009, A guide and guard: the many faces of T-cadherin, Cell. Signal., 21, 1035, 10.1016/j.cellsig.2009.01.035 Philippova, 2012, T-cadherin attenuates insulin-dependent signalling, eNOS activation, and angiogenesis in vascular endothelial cells, Cardiovasc. Res., 93, 498, 10.1093/cvr/cvs004 Philippova, 2011, T-cadherin is present on endothelial microparticles and is elevated in plasma in early atherosclerosis, Eur. Heart J., 32, 760, 10.1093/eurheartj/ehq206 Pischon, 2004, Plasma adiponectin levels and risk of myocardial infarction in men, JAMA, 291, 1730, 10.1001/jama.291.14.1730 Prugger, 2012, Adipocytokines and the risk of ischemic stroke: the PRIME Study, Ann. Neurol., 71, 478, 10.1002/ana.22669 Putku, 2015, CDH13 promoter SNPs with pleiotropic effect on cardiometabolic parameters represent methylation QTLs, Hum. Genet., 134, 291, 10.1007/s00439-014-1521-6 Ramirez, 2020, Single-cell transcriptional networks in differentiating preadipocytes suggest drivers associated with tissue heterogeneity, Nat. Commun., 11, 2117, 10.1038/s41467-020-16019-9 Ranscht, 1991, T-cadherin expression alternates with migrating neural crest cells in the trunk of the avian embryo, Development, 111, 15, 10.1242/dev.111.1.15 Ranscht, 1991, T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region, Neuron, 7, 391, 10.1016/0896-6273(91)90291-7 Rask-Madsen, 2010, Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice, Cell Metab., 11, 379, 10.1016/j.cmet.2010.03.013 Rubina, 2007, T-cadherin suppresses angiogenesis in vivo by inhibiting migration of endothelial cells, Angiogenes., 2007, 183, 10.1007/s10456-007-9072-2 Rubina, 2005, LDL induces intracellular signalling and cell migration via atypical LDL-binding protein T-cadherin, Mol. Cell. Biochem., 273, 33, 10.1007/s11010-005-0250-5 Rubina, 2007, T-cadherin as a receptor regulating angiogenesis and blood vessel remodeling, Biol. Membr., 24, 62 Rubina, 2020, Mechanisms of regulation of the targeted grown of nerves and vessels by components of the fibrinolytic system and GPI-anchored navigation receptors, Neurosci. Behav. Physiol., 50, 217, 10.1007/s11055-019-00890-1 Rubina, 2015, Guidance receptors in the nervous and cardiovascular systems, Biochemistry, 80, 1235 Rubina, 2013, T-cadherin stimulates melanoma cell proliferation and mesenchymal stromal cell recruitment, but inhibits angiogenesis in a mouse melanoma model, Res. Dir. Tumor Angiogenes Ruiz, 2019, AdipoR1 and AdipoR2 maintain membrane fluidity in most human cell types and independently of adiponectin, J. Lipid Res., 60, 995, 10.1194/jlr.M092494 Scherer, 1995, A novel serum protein similar to C1q, produced exclusively in adipocytes, J. Biol. Chem., 270, 26746, 10.1074/jbc.270.45.26746 Schwalie, 2018, A stromal cell population that inhibits adipogenesis in mammalian fat depots, Nat., 2018, 103, 10.1038/s41586-018-0226-8 Semina, 2013, Novel mechanism regulating endothelial permeability via T-cadherin-dependent VE-cadherin phosphorylation and clathrin-mediated endocytosis, Mol. Cell. Biochem., 387, 39, 10.1007/s11010-013-1867-4 Shapiro, 1998, The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor, Curr. Biol., 8, 335, 10.1016/S0960-9822(98)70133-2 Straub, 2019, Metabolic messengers: adiponectin, Nat. Metab., 2019, 334, 10.1038/s42255-019-0041-z Strickland, 2002, Diverse roles for the LDL receptor family, Trends Endocrinol. Metab., 13, 66, 10.1016/S1043-2760(01)00526-4 Suzuki, 2007, The oligomeric structure of high molecular weight adiponectin, FEBS Lett., 581, 809, 10.1016/j.febslet.2007.01.046 Takeuchi, 2001, Recent progress in T-cadherin (CDH13, H-cadherin) research, Histol. Histopathol., 16, 1287 Tanaka, 2019, Adiponectin promotes muscle regeneration through binding to T-cadherin, Sci. Rep., 2019, 1 Tkachuk, 1998, Identification of an atypical lipoprotein-binding protein from human aortic smooth muscle as T-cadherin, FEBS Lett., 421, 208, 10.1016/S0014-5793(97)01562-7 Tsao, 2002, Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30kDa (Acrp30), J. Biol. Chem., 277, 29359, 10.1074/jbc.C200312200 Tsugawa-Shimizu, 2021, Increased vascular permeability and severe renal tubular damage after ischemia-reperfusion injury in mice lacking adiponectin or T-cadherin, Am. J. Physiol. Endocrinol. Metab., 320, E179, 10.1152/ajpendo.00393.2020 Tyrberg, 2011, T-cadherin (Cdh13) in association with pancreatic β-cell granules contributes to second phase insulin secretion, Islets., 3, 327, 10.4161/isl.3.6.17705 Ueno, 2005, Regulation of insulin signalling by hyperinsulinaemia: role of IRS-1/2 serine phosphorylation and the mTOR/p70 S6K pathway, Diabetologia, 48, 506, 10.1007/s00125-004-1662-6 Vestal, 1992, Glycosyl phosphatidylinositol--anchored T-cadherin mediates calcium-dependent, homophilic cell adhesion, J. Cell Biol., 119, 451, 10.1083/jcb.119.2.451 Wang, 2017, T-cadherin deficiency increases vascular vulnerability in T2DM through impaired NO bioactivity, Cardiovasc. Diabetol., 16, 12, 10.1186/s12933-016-0488-0 Wang, 2005, Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner, J. Biol. Chem., 280, 18341, 10.1074/jbc.M501149200 Wang, 2008, Post-translational modifications of adiponectin: mechanisms and functional implications, Biochem. J., 409, 623, 10.1042/BJ20071492 Werner, E.D., J. Lee, L. Hansen, M. Yuan, and S.E. Shoelson. 2004, 279, 35298–35305. Insulin resistance due to phosphorylation of insulin receptor substrate-1 at serine 302, Insulin Resistance Due to Phosphorylation of Insulin Receptor Substrate-1 at Serine 302*. doi:10.1074/jbc.M405203200. Whitehead, 2006, Adiponectin – a key adipokine in the metabolic syndrome, Diabetes, Obes. Metab., 8, 264, 10.1111/j.1463-1326.2005.00510.x Wyder, 2000, Increased expression of H/T-cadherin in tumor-penetrating blood vessels 1, CANCER Res., 60, 4682 Yamauchi, 2003, Cloning of adiponectin receptors that mediate antidiabetic metabolic effects, Nature, 423, 762, 10.1038/nature01705 Yamauchi, 2001, The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity, Nat. Med., 7, 941, 10.1038/90984 Ye, J.J., X. Bian, J. Lim, R. Medzhitov. 2020. Adiponectin and related C1q/TNF-related proteins bind selectively to anionic phospholipids and sphingolipids. Proc. Natl. Acad. Sci. 117:17381–17388. doi:〈10.1073/PNAS.1922270117〉. Zhao, 2007, Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes, Diabetes, 56, 1210, 10.2337/db06-0719 Рубина, К.А., Е.А. Семина, М.Н. Балацкая, О.С. Плеханова, В.А. Ткачук 2018. МЕХАНИЗМЫ РЕГУЛЯЦИИ НАПРАВЛЕННОГО РОСТА НЕРВОВ И СОСУДОВ КОМПОНЕНТАМИ ФИБРИНОЛИТИЧЕСКОЙ СИСТЕМЫ И GPI-ЗАЯКОРЕННЫМИ НАВИГАЦИОННЫМИ РЕЦЕПТОРАМИ, “Российский физиологический журнал им. И.М. Сеченова.” Российский физиологический журнал им. И. М. Сеченова. 1001–1026. 〈doi:10.7868/S0869813918090010〉.